Influence of gender on the pharmacokinetics and pharmacodynamics of drugs

International Journal of Clinical Pharmacology and Therapeutics

Volumn 36, Issue 11, 1998, Pages 586-590

  Thurmann P A ^a   Hompesch, B C ^b  

^a HELIOS KLINIKUM WUPPERTAL   (Germany)

^b NONE

Author keywords

Drug therapy; Gender differences; Pharmacodynamics; Pharmacokinetics; Side effects

Indexed keywords

CYTOCHROME P450; DOPAMINE RECEPTOR; ESTROGEN; GESTAGEN; HORMONE; ORAL CONTRACEPTIVE AGENT;

ADVERSE DRUG REACTION; CONFERENCE PAPER; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG RESEARCH; ENDOTHELIUM; FEMALE; GLUCURONIDATION; HUMAN; MALE; PHARMACODYNAMICS; PHARMACOKINETICS; SEX DIFFERENCE;

AGING; CARDIOVASCULAR AGENTS; FEMALE; HUMANS; MALE; PSYCHOTROPIC DRUGS; SEX CHARACTERISTICS;

EID: 0031742830     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (37)

1. Boudíková B, Szumlanski C, Maidak B, Weinshilboum R 1990 Human liver catechol-O-methyltransferase pharmacogenetics. Clin Pharmacol Ther 48: 381-389
2. Breithaupt-Grögler K, Heger-Mahn D, Klipping C, Butzer R, Duijkers I, Geyer D, Hermann R, Hinze C, Mahler M, Seibert-Grafe M 1997 Klinische Arzneimittelprüfung an Frauen. Dtsch Ärztebl 94: A991-993
3. Bruguerolle B, Toumi M, Farai J, Vervloet D, Razzouk H 1990 Influence of the menstrual cycle on theophylline pharmaeokinetics in asthmatics. Eur J Clin Pharmacol 39: 59-61
4. Charney P, Meyer BR, Frishman WH, Ginsberg A, Eastwood B 1997 Gender, race, and genetic issues in cardiovascular pharmacotherapeutics. In: Frishman WH, Sonnenblick EH (eds) Cardiovascular Pharmacotherapeutics. McGraw-Hill, New York, pp 1347-1361
5. Chowienczyk PJ, Watts GF, Cockcroft JR, Brett SE, Ritter JM 1994 Sex differences in endothelial function in normal and hypercholesterolaemic subjects. Lancet 344: 305-306
6. Clyne CA 1990 Antithrombotic therapy in the primary and secondary prevention of coronary related death and infarction: Focus on gender differences. Cardiology 77 (Suppl 2): 99-109
7. Cotton DJ, Finkelstein DM, He W, Feinberg J for the AIDS Clinical Trials Group 1993 Determinants of accrual of women to a large multicenter clinical trials program of human immunodeficiency virus infection. J AIDS 6: 1322-1328
8. Dawkins K, Potter WZ 1991 Gender differences in pharmacokinetics and pharmacodynamics of psychotropics: focus on woman. Psychopharmacol Bull 27: 417-426
9. Giusti RM, Iwamoto K, Hatch E 1995 Diethylstilbestrol revisited: a review of the long-term health effects. Ann Intern Med 122: 778-788
10. Gleiter CH, Gundert-Remy U 1996 Gender differences in pharmacokinetics. Eur J Drug Metab Pharmacokinet 21: 123-128
11. Gueyffier F, Boutitie F, Boissel JP, Pocock S, Coope J, Cutler J, Ekbom T, Fagard R, Friedman L, Perry M, Prineas R, Schron E 1997 Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials. Ann Intern Med 126: 761-767
12. Homeida M, Halliwell M, Branch RA 1978 Effects of an oral contraceptive on hepatic size and antipyrine metabolism in premenopausal women Clin Pharmacol Ther 24: 228-232
13. Isles CG, Hole DJ, Hawthorne VM, Lever AF 1992 Relation between coronary risk and coronary mortality in woman of the Renfrew and Paisley survey: comparison with men. Lancet 339: 702-706
14. Jochemsen R, van der Graaff M, Boeijinga JK, Breimer DD 1982 Influence of sex, menstrual cycle, and oral contraception on the disposition of nitrazepam. Br J Clin Pharmacol 13: 319-324
15. Kassell NF, Haley Jr EC, Apperson-Hansen C, Alves WM 1996 Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand. J Neurosurg 84: 221-228
16. 2 generation. Thromb Res 24: 163-168
17. Kendall MJ, Quarterman CP, Jack DB, Beeley L 1982 Metoprolol pharmacokinetics and the oral contraceptive pill. Br J Clin Pharmacol 14: 120-122
18. Kubota K, Kubota N, Pearce GL, Inman WHW 1996 ACE inhibitor-induced cough, an adverse drug reaction unrecognised for several years: studies in Prescription-Event Monitoring. Eur J Clin Pharmacol 49: 431-437
19. Lacarelle B, Rahman R, De Sousa O 1991 Metabolism of digoxin, digitoxosides, and digoxigenin in human hepatocytes and liver microsomes. Fund Clin Pharmacol 5: 576
20. Lew KH, Ludwig EA, Milad MA, Donovan K, Middleton jr E, Ferry JJ, Jusko WJ 1993 Pharmacodynamics and drug action. Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther 54: 402-414
21. Lin JH, Chiba M, Chen IW, Nishime JA, Vastag KJ 1996 Sex-dependent pharmacokinetics of indinavir. In vivo and in vitro evidence. Drug Metab Dispos 24: 1298-1306
22. Makkar RR, Fromm BS, Steinman RT, Meissner MD, Lehmann MH 1993 Female gender as a risk factor for Torsades de Pointes associated with cardiovascular drugs. JAMA 270: 2590-2597
23. Miners J, Attwood J, Birkett DJ 1983 Influence of sex and oral contraceptive steroids on paracetamol metabolism. Br J Clin Pharmacol 16: 503-509
24. Miners JO, Grgurinovich N, Whitehead AG, Robson RA, Birkett DJ 1986 Influence of gender and oral contraceptive steroids on the metabolism of salicylic acid and acetylsalicylic acid. Br J Clin Pharmacol 22: 135-142
25. Nafziger AN, Bertino Jr JS 1989 Sex-related differences in theophylline pharmacokinetics. Eur J Clin Pharmacol 37: 97-100
26. Ochs HR, Greenblatt DJ, Divoll M, Abernethy DR, Feyerabend H, Dengler HJ 1981 Diazepam kinetics in relation to age and sex. Pharmacology 23: 24-30
27. Opjordsmoen S 1991 Long-term clinical outcome of schizophrenia with special reference to gender differences. Acta Psychiatr Scand 83: 307-313
28. Rich-Edwards JW, Manson JE, Hennekens CH, Buring JE 1995 The primary prevention of coronary heart disease in woman. N Engl J Med 332: 1758-1766
29. Schmucker DL, O'Mahoy MS, Vesell ES 1994 Women in clinical drug trials. An update. Clin Pharmacokinet 27: 411-417
30. Spranger M, Aspey BS, Harrison MJ 1989 Sex differences in antithrombotic effects of aspirin. Stroke 20: 34-37
31. Strocchi E, Malini PL, Valtancoli G, Ricci C, Bassein L, Ambrosioni E 1992 Cough during treatment with angiotensin-converting enzyme inhibitors. Analysis of predisposing factors. Drug Invest 4: 69-72
32. Swann JR, Reinstein PF 1992 Annual Adverse Drug Experience Report, FDA Report, Rockville
33. Teichmann AT 1990 Influence of oral contraceptives on drug therapy. Am J Obstet Gynecol 163: 2208-2213
34. Walle T, Walle K, Cowart D, Conradi EC 1989 Pathway-selective sex differences in the metabolic clearance of propranolol in human subjects. Clin Pharmacol Ther 46: 257-263
35. Wenger NK, Speroff L, Packard B 1993 Cardiovascular health and disease in woman. N Engl J Med 329: 247-256
36. Wilson K 1984 Sex-related differences in drug disposition in man. Clin Pharmacokinet 9: 189-202
37. Yonkers KA, Kando JC, Cole JO, Blumenthal S 1992 Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medication. Am J Psychiatry 149: 587-595